Abstract
Introduction: The COVID-19 pathophysiology caused by SARS-Cov-2 is closely related
to immunoregulation and the process of inflammation. There are therapeutic targets in both,
which are ideal for the healing process of infected patients. Phytonutrients are closely related to nutrigenomics.
Curcumin and gingerol are two types of phytonutrients that have been studied, researched,
and developed as therapeutic agents for diseases.
Objective: This study aimed to examine the potential of curcumin and gingerol as immune regulators
and anti-inflammatory agents in SARS-CoV-2 infections using a nutrigenomic approach.
Methods: The literature review method was used in this study. Relevant information was gathered
from scientific engines and databases (Google Scholar, Elsevier, Science Direct, Scopus, Wiley Online
Library, PubMed) published during 2010-2021, and the data were analyzed by deductive qualitative
descriptive technique.
Results and Discussion: Curcumin in turmeric and gingerol in ginger have the potential to be used
as a therapy for COVID-19 as they could be immune regulators and anti-inflammatory agents for
SARS-CoV-2 infection. Curcumin and gingerol can act as primary and secondary antioxidants that
can activate endogenous antioxidant enzymes, regulate cell signaling related to immunity such as
interferons, nuclear factor-kappa beta, nitric oxide, and tumor necrosis factor-alpha, as well as stimulate
anti-inflammatory and pro-inflammatory cytokine homeostasis, especially interleukins
(IL-1β, IL-6, IL-17, IL-8). In silico, these two compounds were also proven to have potential as
SARS-CoV-2 antivirals by acting as viral protease inhibitors.
Conclusion: The combination of curcumin and gingerol showed synergistic activity with increasing
antioxidant and anti-inflammatory capacities. Thus, it has great potential for use in COVID-19
therapy.
Keywords:
SARS-CoV-2, COVID-19, nutrigenomic, curcumin, gingerol, coronavirus.
Graphical Abstract
[8]
Indriani, U.; Idiawati, N.; Wibowo, M.A. Uji aktivitas antiinflamasi dan toksisitas infus. Kim. Khatulistiwa, 2018, 7(2), 107-112.
[28]
Sarada, T.M. Attenuation of NFkB activation augments alveolar transport proteins expression and activity under hypoxia. Int. J. Sci. Res., 2015, 4(3), 2230-2237.
[47]
Gamage, K.; Dissanayake, C.; Angoda, W.; Chandrasiri Waliwita, L.; Liyanage, R.P. A review on medicinal uses of Zingiber Officinale (Ginger). Int. J. Health Sci. Res., 2020, 10(6), 142.
[63]
Singh, R.; Mehta, A.; Mehta, P.; Petel, J.R. In vivo evaluation for anti-inflammatory activities of hyro alcoholic combined extracts of Curcuma Longa and Zingiber Officinale Rhizomes. J. Nov. Res. Pharm. Technol., 2014, 1(2), 13-19.
[76]
Marbawati, D.; Umniyati, S.R. Uji Anti virus senyawa kurkumin dan pgv-0 pada virus dengue-2 Dengan RT-PCR antiviral test of curcumin and PGV-0 on Dengue-2 virus by RT-PCR. BALABA, 2016, 45(1), 15-22.
[83]
Abdel-Moneim, A.; Morsy, B.M.; Mahmoud, A.M.; Abo-Seif, M.A.; Zanaty, M.I. Original article : Beneficial therapeutic effects of nigella sativa. EXCLI J., 2013, 12(Lc), 943-955.
[84]
El-adawi, H.; El-demellawy, M.; El-wahab, A.A. Some Medicinal Plant Extracts Exhibit Potency Against Viral Hepatitis C. J. Biosci. Technol., 2011, 2(1), 223-231.
[90]
Elsayed, N.M.; Allehyani, N.M.M.; Elzahar, K.M.; Mostafa, A.A.Z.M. Ginger as a possible treatment for COVID-19. Biosci. Res., 2020, 17(4), 4112-4117.
[93]
Maizura, M.; Aminah, A.; Aida, W.M.W. Total phenolic content and antioxidant activity of kesum (Polygonum Minus), ginger (Zingiber Officinale) and turmeric (Curcuma Longa) extract. Int. Food Res. J., 2011, 18(2), 526-531.
[94]
Sahoo, N.; Mishra, S.K.; Swain, R.K.; Acharya, A.P.; Pattnaik, S.; Sethy, K.; Sahoo, L. Effect of turmeric and ginger supplementation on immunity, antioxidant, liver enzyme activity, gut bacterial load and histopathology of broilers. Indian J. Anim. Sci., 2019, 89(7), 774-779.